Table 1.
Patients’ demographics
| 2019 (control group) (N=117) | 2020 (pandemic group) (N=92) | P | ||
|---|---|---|---|---|
| Sex | Female | 49 (41.9) | 46 (50) | 0.265 |
| Male | 68 (58.1) | 46 (50) | ||
| Age | 35.26±19.718 | 34.50±20.609 | 0.788 | |
| BMI (kg/m2) | 27.0±7.0 | 26.2±5.2 | 0.470 | |
| ASA score | 1 | 64 (56.1) | 51 (55.4) | 0.169 |
| 2 | 47 (41.2) | 34 (37.0) | ||
| 3 | 2 (1.8) | 7 (7.6) | ||
| 4 | 1 (0.9) | 0 (0) | ||
| Diabetes | 5 (4.27) | 2 (2.17) | 0.469 | |
| COPD | 1 (0.855) | 5 (5.43) | 0.089 | |
| Smoking | 19 (16.24) | 12 (13.19) | 0.563 | |
| Coronary artery disease | 3 (2.56) | 4 (4.35) | 0.702 | |
| Immunosuppression | 2 (1.71) | 1 (1.09) | 1.000 | |
| Neurocognitive disorders | 0 (0) | 2 (2.17) | 0.193 | |
ASA, American Society of Anesthesiologists; COPD, chronic obstructive pulmonary disease.
Statistical significance was set at P<0.05.